Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity

Journal of Neuroinflammation

Volumn 3, Issue , 2006, Pages

  Maezawa, Izumi ^a   Zaja Milatovic, Snjezana ^a   Milatovic, Dejan ^a   Stephen, Christina ^a   Sokal, Izabela ^a   Maeda, Nobuyo ^a   Montine, Thomas J ^a   Montine, Kathleen S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CD14 ANTIGEN; ISOPROTEIN; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CELL CULTURE; CELL REGENERATION; CELL SIZE; CONTROLLED STUDY; CULTURE MEDIUM; DEGENERATIVE DISEASE; DENDRITE; FEMALE; GENE ACTIVATION; GOLGI STAIN; HIPPOCAMPUS; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NERVE FIBER GROWTH; NEUROTROPISM; NONHUMAN; PARACRINE SIGNALING; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; WESTERN BLOTTING;

EID: 33749414025     PISSN: 17422094     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-3-21     Document Type: Article

References (59)

1. Polazzi E, Contestabile A: Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev Neurosci 2002, 13:221-2242.
2. Wyss-Coray T, Mucke L: Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002, 35:419-432.
3. Milatovic D, Zaja-Milatovic S, Montine KS, Horner PJ, Montine TJ: Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J Neurochem 2003, 87:1518-1526.
4. Stern EL, Quan N, Proescholdt MG, Herkenham M: Spatiotemporal induction patterns of cytokine and related immune signal molecule mRNAs in response to intrastriatal injection of lipopolysaccharide. J Neuroimmunol 2000, 106:114-129.
5. Montine TJ, Milatovic D, Gupta RC, Valyi-Nagy T, Morrow JD, Breyer RM: Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J Neurochem 2002, 83:463-470.
6. Nadeau S, Rivest S: Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J Neurosci 2003, 23:5536-5544.
7. Nadeau S, Rivest S: Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14. J Immunol 2002, 169:3370-3381.
8. Hauss-Wegrzyniak B, Lynch MA, Vraniak PD, Wenk GL: Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp Neurol 2002, 176:336-341.
9. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T: Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 2003, 100:8514-8519.
10. Wenk GL, McGann-Gramling K, Hauss-Wegrzyniak B, Ronchetti D, Maucci R, Rosi S, Gasparini L, Ongini E: Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. J Neurochem 2004, 89:484-493.
11. Imler JL, Hoffmann JA: Toll receptors in innate immunity. Trends Cell Biol 2001, 11:304-311.
12. Akira S: Toll-like receptor signaling. J Biol Chem 2003, 278:38105-38108.
13. Johnson GB, Brunn GJ, Platt JL: Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol 2003, 23:15-44.
14. Fassbender K, Walter S, Kuhl S, Landmann R, Ishii K, Bertsch T, Stalder AK, Muehlhauser F, Liu Y, Ulmer AJ, Rivest S, Lentschat A, Gulbins E, Jucker M, Staufenbiel M, Brechtel K, Walter J, Multhaup G, Penke B, Adachi Y, Hartmann T, Beyreuther K: The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 2004, 18:203-205.
15. Moffatt OD, Devitt A, Bell ED, Simmons DL, Gregory CD: Macrophage recognition of ICAM-3 on apoptotic leukocytes. J Immunol 1999, 162:6800-6810.
16. Sholl DA: Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 1953, 87:387-406.
17. Milatovic D, Zaja-Milatovic S, Montine KS, Shie FS, Montine TJ: Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo. J Neuroinflammation 2004, 1:20.
18. Milatovic D, Zaja-Milatovic S, Montine KS, Nivison M, Montine TJ: CD14-dependent innate immunity-mediated neuronal damage in vivo is suppressed by NSAIDS and ablation of a pros-taglandin E2 receptor, EP2. Current Medicinal Chemistry 2005, 5:151-156.
19. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
20. Strittmatter WJ, Roses AD: Apolipoprotein E and Alzheimer's disease. Proc Natl Acad Sci 1995, 92:4725-4727.
21. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter WJ, Saunders AM, Roses AD: APOE genotype and survival from intracerebral hemorrhage. Lancet 1995, 346:575.
22. Newman MF, Croughwell ND, Blumenthal JA, Lowry E, White WD, Spillane W, Davis RD, Glower DD, Smith LR, Mahanna EP: Predictors of cognitive decline after cardiac operation. Ann Thorac Surg 1995, 59:1326-1330.
23. Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Mastaglia. F, Haines JL, Pericak-Vance MA, Vance JM: Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 2004, 62:2005-2009.
24. Li YJ, Pericak-Vance MA, Haines JL, Siddique N, McKenna-Yasek D, Hung WY, Sapp P, Allen Cl, Chen W, Hosler B, Saunders AM, Dellefave LM, Brown RHJ, Siddique T: Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics 2004, 5:209-213.
25. Enzinger C, Ropele S, Smith S, Strasser-Fuchs S, Poltrum B, Schmidt H, Matthews PM, Fazekas F: Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4. Ann Neurol 2004, 55:563-569.
26. Nathoo N, Chetty R, van Dellen JR, Barnett GH: Genetic vulnerability following traumatic brain injury: the role of apollipoprotein E. Mol Pathol 2003, 56:132-136.
27. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S: Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA 1997, 278:136-140.
28. Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C: HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998, 4:1182-11184.
29. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PJ, Rimmler JB, Locke PA, Conneally PM, Schmader KE, al.: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994, 7:180-184.
30. Ophir G, Amariglio, N, Jacob-Hirsch J, Elkon R, Rechavi G, Michaelson DM: Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade. Neurobiol Dis 2005, 20:709-718.
31. Ophir G, Meilin S, Efrati M, Chapman J, Karussis D, Roses A, Michaelson DM: Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice. Neurobiol Dis 2003, 12:56-64.
32. Colton CA, Brown CM, Cook D, Needham LK, Xu Q, Czapiga M, Saunders AM, Schmechel DE, Rasheed K, Vitek MP: APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging 2002, 23:777-785.
33. Brown CM, Wright E, Colton CA, Sullivan PM, Laskowitz DT, Vitek MP: Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med 2002, 32:1071-1075.
34. Mahley RW, Rall SCJ: Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000, 1:507-537.
35. Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, Warner DS, Laskowitz DT: APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 2003, 278:48529-48533.
36. Li FQ, Sempowski GD, McKenna SE, Laskowitz DT, Colton CA, Vitek MP: Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. J Pharmacol Exp Ther 2006.
37. McAdoo JD, Warner DS, Goldberg RN, Vitek MP, Pearlstein R, Laskowitz DT: Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury. Neurosci Lett 2005, 381:305-308.
38. Aono M, Bennett ER, Kim KS, Lynch JR, Myers J, Pearlstein RD, Warner DS, Laskowitz DT: Protective effect of apolipoprotein E-mimetic peptides on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cell cultures. Neuroscience 2003, 116:437-445.
39. Maezawa I, Nivison M, Montine KS, Maeda N, Montine TJ: Neuro-toxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK. Faseb J 2006, 20:797-799.
40. Maezawa I, Maeda N, Montine TJ, Montine KS: Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice. J Neuroinflammation 2006, 3:10.
41. Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N: Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 1997, 272:17972-17980.
42. Sullivan PM, Mezdour H, Quarfordt SH, Maeda N: Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J Clin Invest 1998, 102:130-135.
43. Maezawa I, Jin LW, Woltjer RL, Maeda N, Martin GM, Montine TJ, Montine KS: Apolipoprotein E isoforms and apolipoprotein Al protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity. J Neuorchem 2004, 91:1312-1321.
44. Xiang J, Chao DT, Korsmeyer SJ: BAX-induced cell death may not require interleukin I beta-converting enzyme-like proteases. Proc Natl Acad Sci U S A 1996, 93:14559-14563.
45. Sullivan PM, Mace BE, Maeda N, Schmechel DE: Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience 2004, 124:725-733.
46. LaDu MJ, Shah JA, Reardon CA, Getz GS, Bu G, Hu J, Guo L, Van Eldik LJ: Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses. Neurochem Int 2001, 39:427-434.
47. Herz J, Qiu SQ, Oesterle A, DeSilva HV, Shafi S, Havel RJ: Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc Natl Acad Sci U S A 1995, 92:4611-4615.
48. Howard GC, Roberts BC, Epstein DL, Pizzo SV: Characterization of alpha 2-macroglobulin binding to human trabecular meshwork cells: presence of the alpha 2-macroglobulin signaling receptor. Arch Biochem Biophys 1996, 333:19-26.
49. Mahley RW, Weisgraber KH, Huang Y: Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 2006, 103:5644-5651.
50. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE: Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994, 264:850-852.
51. Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, Mahley RW, Pitas RE: The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 1995, 270:19791-19799.
52. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL: Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci U S A 1995, 92:9480-9484.
53. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE: Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 1995, 270:27063-27071.
54. Narita M, Bu G, Holtzman DM, Schwartz AL: The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J Neurochem 1997, 68:587-595.
55. Fagan AM, Bu G, Sun Y, Daugherty A, Holtzman DM: Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem 1996, 271:30121-30125.
56. DeMattos RB, Curtiss LK, Williams DL: A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J Biol Chem 1998, 273:4206-4212.
57. Sun YL, Wu S, Bu GJ, Onifade MK, Patel SN, Ladu MJ, Fagan AM, Holtzman DM: Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice- astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci 1998, 18:3261-3272.
58. Nathan BP, Jiang Y, Wong GK, Shen F, Brewer GJ, Struble RG: Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res 2002, 928:96-105.
59. Ji Y, Gong Y, Gan W, Beach T, Holtzman DM, Wisniewski T: Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 2003, 122:305-315.